Cargando…
Cognitive Enhancement
This book highlights the behavioral and neurobiological issues relevant for drug development, reviews evidence for an innovative approach for drug discovery and presents perspectives on multiple special topics ranging from therapeutic drug use in children, emerging technologies and non-pharmacologic...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Cham :
Springer International Publishing : Imprint: Springer,
2015.
|
| Edición: | 1st ed. 2015. |
| Colección: | Handbook of Experimental Pharmacology,
228 |
| Temas: | |
| Acceso en línea: | Texto Completo |
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-3-319-16522-6 | ||
| 003 | DE-He213 | ||
| 005 | 20220115125123.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 150514s2015 sz | s |||| 0|eng d | ||
| 020 | |a 9783319165226 |9 978-3-319-16522-6 | ||
| 024 | 7 | |a 10.1007/978-3-319-16522-6 |2 doi | |
| 050 | 4 | |a RM300-666 | |
| 072 | 7 | |a MMG |2 bicssc | |
| 072 | 7 | |a MED071000 |2 bisacsh | |
| 072 | 7 | |a MKG |2 thema | |
| 082 | 0 | 4 | |a 615 |2 23 |
| 245 | 1 | 0 | |a Cognitive Enhancement |h [electronic resource] / |c edited by Kathleen M. Kantak, Joseph G. Wettstein. |
| 250 | |a 1st ed. 2015. | ||
| 264 | 1 | |a Cham : |b Springer International Publishing : |b Imprint: Springer, |c 2015. | |
| 300 | |a VIII, 470 p. 30 illus., 24 illus. in color. |b online resource. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 1 | |a Handbook of Experimental Pharmacology, |x 1865-0325 ; |v 228 | |
| 505 | 0 | |a Preface -- Part 1. Basic Approaches and Perspectives -- Part 2. Cognitive Domains for Pharmacological Intervention: Implications for Neuropsychiatric and Neurological Illnesses -- Part 3. Developmental Disorders, Emerging Technologies and Ethical Considerations. | |
| 520 | |a This book highlights the behavioral and neurobiological issues relevant for drug development, reviews evidence for an innovative approach for drug discovery and presents perspectives on multiple special topics ranging from therapeutic drug use in children, emerging technologies and non-pharmacological approaches to cognitive enhancement. | ||
| 650 | 0 | |a Pharmacology. | |
| 650 | 0 | |a Neurosciences. | |
| 650 | 0 | |a Neurology . | |
| 650 | 0 | |a Psychiatry. | |
| 650 | 1 | 4 | |a Pharmacology. |
| 650 | 2 | 4 | |a Neuroscience. |
| 650 | 2 | 4 | |a Neurology. |
| 650 | 2 | 4 | |a Psychiatry. |
| 700 | 1 | |a Kantak, Kathleen M. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Wettstein, Joseph G. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9783319165233 |
| 776 | 0 | 8 | |i Printed edition: |z 9783319165219 |
| 776 | 0 | 8 | |i Printed edition: |z 9783319351957 |
| 830 | 0 | |a Handbook of Experimental Pharmacology, |x 1865-0325 ; |v 228 | |
| 856 | 4 | 0 | |u https://doi.uam.elogim.com/10.1007/978-3-319-16522-6 |z Texto Completo |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||